![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1234, 2009-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Safety of HPV vaccine in UK in line with expectations
Reactions Weekly, Vol. 1, Iss. 1274, 2009-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
No autoimmune safety signals with HPV4 vaccine
Reactions Weekly, Vol. 1, Iss. 1389, 2012-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
HPV vaccine recombinant quadrivalent: safety concerns
Reactions Weekly, Vol. 1, Iss. 1139, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
HPV vaccine worth a shot in Europe
Inpharma, Vol. 1, Iss. 1614, 2007-01 ,pp. :